Plasma methylated septin 9: a colorectal cancer screening marker

References

• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-403
   PubMed Web of Science ®Google Scholar
• Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence. Br J Surg 2002;89(7):845-60
   PubMed Web of Science ®Google Scholar
• deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009;55(7):1337-46
   PubMed Web of Science ®Google Scholar
• Epi pro colon. Available from: www.epiprocolon.com
   Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67
   PubMed Web of Science ®Google Scholar
• Patai AV, Molnár B, Tulassay Z, et al. Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol 2013;19(5):607-15
   PubMed Web of Science ®Google Scholar
• Levin TR, Jamieson L, Burley DA, et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011;33(1):101-10
   PubMed Web of Science ®Google Scholar
• Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134(5):1570-95
   PubMed Web of Science ®Google Scholar
• Segnan N, Patrick J, Karsa LV, et al. European Guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Office for Official Publications of the European Communities; 2010
   Google Scholar
• Kahi CJ, Myers LJ, Slaven JE, et al. Lower endoscopy reduces colorectal cancer incidence in older individuals. Gastroenterology 2014;146(3):718-25
   PubMed Web of Science ®Google Scholar
• Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375(9726):1624-33
   PubMed Web of Science ®Google Scholar
• Wong CK, Fedorak RN, Prosser CI, et al. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis 2012;27(12):1657-64
   PubMed Web of Science ®Google Scholar
• Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142(2):248-56
   PubMed Web of Science ®Google Scholar
• Kerr J, Day P, Broadstock M, et al. Systematic review of the effectiveness of population screening for colorectal cancer. N Z Med J 2007;120(1258):U2629
   PubMedGoogle Scholar
• Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenterol 2012;6:20-9
   Google Scholar
• Newton KF, Newman W, Hill J. Review of biomarkers in colorectal cancer. Colorectal Dis 2012;14(1):3-17
   PubMed Web of Science ®Google Scholar
• Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009;361(25):2449-60
   PubMed Web of Science ®Google Scholar
• Gibson J, Lacy J, Matloff E, et al. Microsatellite instability testing in colorectal carcinoma: a practical guide. Clin Gastroenterol Hepatol 2014;12(2):171-6
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96(15):8681-6
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38(7):787-93
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487(7407):330-7
   PubMed Web of Science ®Google Scholar
• Peters U, Hutter CM, Hsu L, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2012;131:217-34
   PubMed Web of Science ®Google Scholar
• Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13(7):484-92
   PubMed Web of Science ®Google Scholar
• Fukushige S, Horii A. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers. Tohoku J Exp Med 2013;229(3):173-85
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, West J, Beck S. Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet 2013;22(R1):R7-R15
   PubMed Web of Science ®Google Scholar
• Heichman KA. Blood-based testing for colorectal cancer screening. Mol Diagn Ther 2014;18(2):127-35
   PubMed Web of Science ®Google Scholar
• Marshall KW, Mohr S, Khettabi FE, et al. A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer 2010;126(5):1177-86
   PubMed Web of Science ®Google Scholar
• Brock R, Xiong B, Li L, et al. A multiplex serum protein assay for determining the probability of colorectal cancer. Am J Cancer Res 2012;2(5):598-605
   PubMed Web of Science ®Google Scholar
• Zhang B, Chen JY, Chen DD, et al. Tumor type M2 pyruvate kinase. Expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol 2004;10:1643-6
   PubMed Web of Science ®Google Scholar
• Staib P, Hoffmann M, Schinköthe T. Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors. Clin Chem Lab Med 2006;44(1):28-31
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Burges A, Reich O, et al. DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann N Y Acad Sci 2008;1137:162-70
   PubMed Web of Science ®Google Scholar
• Mostert B, Jiang Y, Sieuwerts AM, et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int J Cancer 2013;133(1):130-41
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Wang L, et al. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer. J Surg Oncol 2014;109(6):574-9
   PubMed Web of Science ®Google Scholar
• LaPointe LC, Pedersen SK, Dunne R, et al. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS One 2012;7(1):e29059
   Web of Science ®Google Scholar
• Toiyama Y, Takahashi M, Hur K, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013;105(12):849-59
   PubMedGoogle Scholar
• Kanaan Z, Rai SN, Eichenberger MR, et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 2012;256(3):544-51
   PubMed Web of Science ®Google Scholar
• McIlhatton MA, Burrows JF, Donaghy PG, et al. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 2001;20(41):5930-9
   PubMed Web of Science ®Google Scholar
• Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004;204(4):489-505
   PubMed Web of Science ®Google Scholar
• Amir S, Golan M, Mabjeesh NJ. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Mol Cancer Res 2010;8(5):643-52
   PubMed Web of Science ®Google Scholar
• Mostowy S, Janel S, Forestier C, et al. A role for septins in the interaction between the Listeria monocytogenes invasion protein InlB and the Met receptor. Biophys J 2011;100(8):1949-59
   PubMed Web of Science ®Google Scholar
• Mostowy S, Nam Tham T, Danckaert A, et al. Septins regulate bacterial entry into host cells. PLoS One 2009;4(1):e4196
   PubMed Web of Science ®Google Scholar
• Estey MP, Di Ciano-Oliveira C, Froese CD, et al. Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis. J Biol Chem 2013;288(42):30075-86
   PubMed Web of Science ®Google Scholar
• Sellin ME, Holmfeldt P, Stenmark S, et al. Microtubules support a disk-like septin arrangement at the plasma membrane of mammalian cells. Mol Biol Cell 2011;22(23):4588-601
   PubMed Web of Science ®Google Scholar
• Field CM, Kellogg D. Septins: cytoskeletal polymers or signalling GTPases? Trends Cell Biol 1999;9(10):387-94
   PubMed Web of Science ®Google Scholar
• Golan M, Mabjeesh NJ. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation. Cell Cycle 2013;12(14):2297-308
   PubMed Web of Science ®Google Scholar
• Scott M, Hyland PL, McGregor G, et al. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 2005;24(29):4688-700
   PubMed Web of Science ®Google Scholar
• Montagna C, Lyu MS, Hunter K, et al. The Septin9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003;63(9):2179-87
   PubMed Web of Science ®Google Scholar
• Kim DS, Hubbard SL, Peraud A, et al. Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia 2004;6(2):168-78
   PubMed Web of Science ®Google Scholar
• Gulten T, Yakut T, Karkucak M, et al. AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia. J Clin Lab Anal 2009;23(6):368-71
   PubMed Web of Science ®Google Scholar
• Kreuziger LM, Porcher JC, Ketterling RP, et al. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk Res 2007;31(8):1145-8
   PubMed Web of Science ®Google Scholar
• Bennett KL, Karpenko M, Lin MT, et al. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008;68(12):4494-9
   PubMed Web of Science ®Google Scholar
• Scott M, McCluggage WG, Hillan KJ, et al. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 2006;118(5):1325-9
   PubMed Web of Science ®Google Scholar
• Connolly D, Yang Z, Castaldi M, et al. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res 2011;13(4):R76
   PubMed Web of Science ®Google Scholar
• Adorján P, Distler J, Lipscher E, et al. Tumour class prediction and discovery by microarray-based DNA methylation analysis. Bioinformatics 2001(Suppl 1):S157-64
   Google Scholar
• Model F, Osborn N, Ahlquist D, et al. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res 2007;5(2):153-63
   PubMed Web of Science ®Google Scholar
• Lewin J, Plum A, Hildmann T, et al. Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisation. Int J Biochem Cell Biol 2007;39(7-8):1539-50
   PubMed Web of Science ®Google Scholar
• Wasserkort R, Kalmar A, Valcz G, et al. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer 2013;13:398
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54(2):414-23
   PubMed Web of Science ®Google Scholar
• Grützmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008;3(11):e3759
   PubMed Web of Science ®Google Scholar
• Tänzer M, Balluff B, Distler J, et al. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 2010;5(2):e9061
   PubMed Web of Science ®Google Scholar
• Payne SR. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood. Epigenomics 2010;2(4):575-85
   PubMed Web of Science ®Google Scholar
• Weiss G, Rösch T. Potential of a new blood test for colorectal cancer screening –the septin 9 gene biomarker. Eur Oncol 2010;6(1):51-4
   Google Scholar
• Church TR, Wandell M, Lofton-Day C, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014;63(2):317-25
   PubMed Web of Science ®Google Scholar
• PRESEPT Study: evaluation of SEPT9 biomarker performance for colorectal cancer screening. Available from: http://clinicaltrials.gov/show/NCT00855348
   Google Scholar
• Information for domestic customers. Available from: www.epiprocolon.com/en/medical-professionals/septin9-test.html
   Google Scholar
• Potter NT, Hurban P, White MN, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Johnson DA, Barclay RL, Mergener K, et al. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One 2014;9(6):e98238
   PubMed Web of Science ®Google Scholar
• Tóth K, Sipos F, Kalmár A, et al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One 2012;7(9):e46000
   PubMed Web of Science ®Google Scholar
• Abbott molecular website. Available from: www.abbottmolecular.com/products/oncology/real-time-pcr/ms9-colorectal-cancer-assay.html
   Google Scholar
• The principal and performance characteristics of the Abbott RealTime mS9 colorectal cancer assay. Available from: http://meetinglibrary.asco.org/content/60888-101
   Google Scholar
• Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 2011;9:133
   PubMed Web of Science ®Google Scholar
• Quest diagnostics website. Available from: www.questdiagnostics.com/testcenter/testguideaction?dc=TH_Sept9 ColoVantage
   Google Scholar
• Warnex medical laboratories product. Available from: www.septin9.ca
   Google Scholar
• Powrozek T, Krawczyk P, Kucharczyk T, Milanowski J. Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report. Med Oncol 2014;31:917
   PubMed Web of Science ®Google Scholar
• Dietrich D, Jung M, Puetzer S, et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions. PLoS One 2013;8:e84225
   Web of Science ®Google Scholar
• Taber JM, Aspinwall LG, Heichman KA, Kinney AY. Preferences for blood-based colon cancer screening differ by race/ethnicity. Am J Health Behav 2014;38:351-61
   PubMed Web of Science ®Google Scholar
• Tham C, Chew M, Soong R, et al. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Cancer 2014; Epub ahead of print
   PubMed Web of Science ®Google Scholar